BACE2 and Alzheimer disease: Besides BACE1 and BACE2, a lysosomal cysteine protease, cathepsin B, was also proposed as an additional β-secretase, as cathepsin B inhibitors demonstrated mitigation of memory deficit and reduction in beta-amyloid concentration related to AD [47].